Novartis to buy 25% of Alcon

Article

Novartis is to purchase 25% of Alcon from majority stakeholder Nestlé, with an option to purchase Nestlé's remaining shares, which currently amount to approximately 52% of Alcon.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
Related Content
A sign in front of palm trees. It reads "Welcome to Florida: The Sunshine State." Concept image for American Academy of Ophthalmology 2025 meeting in Orlando, Florida. Image credit: ©quasarphotos – stock.adobe.com

What to expect at the American Academy of Ophthalmology meeting

Lynda Charters
October 12th 2025
Article
Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
October 12th 2025
Podcast
A child's face, in profile, next to a Snellen chart. Concept image for atropine use in paediatric patients with myopia and long-term effects or complications of atropine and red light therapy. Image credit: ©New Africa – stock.adobe.com

Insights into atropine usage

Lynda Charters
October 12th 2025
Article
A lightbulb hovering in an open box, in a room full of closed boxes. Image concept for "thinking outside the box," and revisiting or amending perspectives to treatment of retinal disease. Image credit: ©masterzphotofo – stock.adobe.com

Broader perspective for the treatment approach on retinal neovascular diseases

Fanka Gilevska, MD, PhD
October 12th 2025
Article
A lectern and podium, with three microphones, in front of the European Union (EU) flag. Concept image for Ophthalmology Times Europe editorial advisory board members presenting at American Academy of Ophthalmology meeting 2025. Image credit: ©corund – stock.adobe.com

AAO 2025: What the Eye Care Network's editorial advisory board members are presenting

Kassi Filkins
October 12th 2025
Article
An elderly woman with glasses sits on a grassy hillside, near a tranquil blue lake. Concept image for geographic atrophy and vision-related quality of life measures. ©CameraCraft – stock.adobe.com

Intravitreal complement inhibitor treatment for GA viewed favorably by patients

Lynda Charters
October 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.